Moreover, an animal study has confirmed that inhibiting the p53 pathway can suppress cardiac fibroblast activation and mitigate the progression of myocardial fibrosis following myocardial infarction (Tamaki et al., 2013). Here, TP53 is linked to myocardial infarction.